Rommelag Marks 50 Years of BFS Technology
Rommelag continues to supply blow-fill-seal machinery, with the brand name bottelpack.
Rommelag announced its 50th year of supplying blow-fill-seal machinery, with the brand name bottelpack. Rommelag is a member of the Hansen Group headed by CEO Bernd Hansen, with sales companies in Switzerland, Germany, the US, and China.
All bottelpack machines operate using the blow-fill-seal principle (BFS), a single automatic process in which containers are created from thermoplastic granules (blow), contents are inserted (fill) and closed (seal). BFS technology does not require the cleaning and sterilization processes that are used in other kinds of container production, according to Rommelag. Used for the aseptic packaging of sterile liquids, creams, ointments and vaccines, the machines are equipped with additional modules for QA and monitoring. Modules include aseptic systems for automatic cleaning and sterilization of lines that come into contact with products.
Rommelag reports that aseptic packaging by means of bottelpack BFS systems is gaining popularity and plastic materials offer advantages to manufacturers and users of infusion containers and ampoules. The packaging can be made very thin without risk of breaking, is easily collapsible, and is chemically inert.
Source: Rommelag
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
Pharmaceutical Tariffs Are Imminent: How Industry is Bracing for Impact
April 16th 2025On April 14, 2025, the Trump Administration launched a national security-driven investigation into pharmaceuticals, a move that will likely result in tariffs being placed on pharmaceutical drugs, ingredients, and other components that are imported from outside of the United States.
